Evaluation of maternal systemic inflammatory response in preeclampsia

Taiwanese Journal of Obstetrics and Gynecology

Volumn 54, Issue 2, 2015, Pages 160-166

  Mihu, Dan ^a   Razvan, Ciortea ^a   Malutan, Andrei ^a   Mihaela, Carmen ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Cytokines; Inflammation; Oxidative stress; Preeclampsia; Pregnancy

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; HYDROGEN; INTERLEUKIN 6; LIPID PEROXIDE; NITRATE; NITRITE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; TNF PROTEIN, HUMAN;

ADULT; APGAR SCORE; ARTICLE; BIRTH; CONTROLLED STUDY; FEMALE; FETUS WEIGHT; GESTATIONAL AGE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; NEUTROPHIL; OXIDATIVE STRESS; PREECLAMPSIA; PROTEIN CARBONYLATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; INFLAMMATION; LEUKOCYTE COUNT; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SYNDROME;

ADULT; APGAR SCORE; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FETAL WEIGHT; GESTATIONAL AGE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE COUNT; NEUTROPHILS; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938866842     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2014.03.006     Document Type: Article

References (64)

1. Vitoratos N., Economou E., Iavazzo C., Panoulis K., Creatsas G. Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women. Mediators Inflamm 2010, 2010:908649.
2. Berg C.J., MacKay A.P., Qin C., Callaghan W.M. Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. Obstet Gynecol 2009, 113:1075-1081.
3. Szarka A., Rigó J., Lázár L., Beko G., Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 2010, 11:59.
4. deOliveira LG Karumanchi A, Sass N. Preeclampsia: oxidative stress, inflammation and endothelial dysfunction. Rev Bras Ginecol Obstet 2010, 32:609-616.
5. Roberts J.M., Hubel C.A. The two stage model of preeclampsia: variations on the theme. Placenta 2009, 30:32-37.
6. Steegers E.A.P., von Dadelszen P., Duvekot J.J., Pijnenborg R. Pre-eclampsia. The Lancet 2010, 376:631-644.
7. Visser N., van Rijn B.B., Rijkers G.T., Franx A., Bruinse H.W. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv 2007, 62:191-201.
8. Garcia R.G., Celedan J., Sierra-Laguado J., Alarson M.A., Luengas C., Silva F., et al. Raised C reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertension 2007, 20:98-103.
9. Wang Y., Gu Y., Zhang Y., Lewis D.F. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preclampsia. Am J Obstet Gynecol 2004, 3:817-824.
10. Jäntschi L., Bolboacă S.D. Exact probabilities and confidence limits for binomial samples: applied to the difference between two proportions. The Scientific World Journal 2010, 10:865-878.
11. Wenda R., Asif A. Is inflammation the cause of pre-eclampsia. Biochem Soc Trans 2011, 39:1619-1627.
12. Belo L., Santos-Silva A., Rocha S., Caslake M., Conney J., Pereira-Leite L., et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 2005, 123:46-51.
13. Aly A.S., Khandelwal M., Ihao J., Mehmet A.H., Sammel M.P., Parry S. Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia. Am J Obstet Gynecol 2004, 190:252-258.
14. Tsukimori K., Fukushima K., Tsushima A., Nakano H. Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies. Hypertension 2005, 46:696-700.
15. Ozkaya O., Sezik M., Sezik H.T., Eyi E.G. Leukocytosis might precede in hospital eclampsia in preeclamptic women who do not receive magnesium sulfate. JPerinat Med 2006, 34:378-382.
16. Coussons-Read M.E., Okun M., Nettels C. Psychosocial stress increases inflammatory markers and alters cytokine production across pregnancy. Brain Behav Immun 2007, 21:343-350.
17. Jansson Y., Ruber M., Matthiesen L., Berg G., Nieminen K., Sharma S., et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. JReprod Immunol 2006, 70:83-91.
18. Afshari T., Ghomian N., Shameli A., Shakeri M.T., Fahmidehkar M.A., Mahajer E., et al. Determination of interleukin-6 and TNF-alpha concentrations in Iranian-Khorasanian patients with preeclampsia. BMC Pregnancy Childbirth 2005, 5:14-19.
19. Xie C., Yao M.Z., Liu J.B., Xiong L.K. Ameta-analysis of tumor necrosis factor-alpha, interleukin-6 and interleukin-10 in preeclampsia. Cytokine 2011, 56:550-559.
20. Kronborg C.S., Gjedsted J., Vittinghus E., Hansen T.K., Allen J., Knudsen U.B. Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet Gynecol Scand 2011, 90:791-796.
21. Orshal J.M., Khali R.A. Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxion and enhances contraction in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol 2004, 286:1013-1023.
22. Takacs P., Green K.L., Nikaco A., Kauma S.V. Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am J Obstet Gynecol 2003, 188:740-744.
23. Luppi P., Dloia J.A. Monocytes of preeclamptic women spontaneously syntesize pro-inflammatory cytokines. Clin Immunol 2006, 118:268-275.
24. Anim-Nyame N., Gamble J., Sooranna S.R., Johnson M.R., Steer P.J. Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia. Cardiovasc Res 2003, 58:162-169.
25. Borekci B., Aksoy H., Al R.A., Demircan B., Kadanali S. Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia. Am J Reprod Immunol 2007, 58:56-64.
26. Jonsson Y., Ruber M., Matthiesen L., Berg G., Nieminen K., Sharma S., et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. JReprod Immunol 2006, 70:83-91.
27. Sharma A., Satyam A., Sharma J.B. Leptin, IL-10 and inflammatory markers (TNF-α, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007, 58:21-30.
28. Al-Othman S., Omu A.E., Diejomaoh F.M.E., Al-Yatama M., Al-Qattan F. Differential levels of interleukin 6 in maternal and cord sera and placenta in women with preeclampsia. Gynecol Obstet Invest 2001, 52:60-65.
29. Muzammil S., Singhal U., Gulati R., Bano I. Serum tumor necrosis factor-alpha in preeclampsia. Indian J Physiol Pharmacol 2005, 49:236-240.
30. Noyan T., Bursal E., Sekeroglu M.R., Dulger H., Kamaci M. The serum interleukin-6 and tumor necrosis factor-alpha levels and their relationship with antithrombin-111 and von Willebrand factor in preeclampsia. JTurkish German Gynecol Assoc 2006, 7:39-44.
31. Cackovic M., Buhimschi C.S., Zhao G., Funai E.F., Norwitz E.R., Kuczynski E., et al. Fractional excretion of tumor necrosis factor-α in women with severe preeclampsia. Obstet Gynecol 2008, 112:93-100.
32. Benyo D.F., Miles T.M., Conrad K.P. Hypoxia stimulates cytokine production by villous explants from the human placenta. JClin Endocrinol Metab 1997, 82:1582-1588.
33. Vaughan J.E., Walsh S.W. Neutrophils from pregnant women produce thromboxane and tumor necrosis factor-a in response to linoleic acid and oxidative stress. Am J Obstet Gynecol 2005, 193:830-835.
34. Peracoli J.C., Rudge M.V.C., Perac Oli MTS. Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am J Reprod Immunol 2007, 57:177-185.
35. Guven M.A., Coskun A., Ertas I.E., Aral M., Zencirci B., Oksuz H. Association of maternal serum CRP, IL-6, TNF-α, homocysteine, folic acid and vitamin b12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Preg 2009, 28:190-200.
36. Sibai B., Romero R., Klebanoff M.A., et al. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol 2009, 200:630.
37. Ertas I.E., Kahyaoglu S., Yilmaz B., Ozel M., Sut N., Gven M.A., et al. Association of maternal serum high sensitive C-reactive protein level with body mass index and severity of pre-eclampsia at third trimester. JObstet Gynaecol Res 2010, 36:970-977.
38. de Jonge L.L., Steegers E.A., Ernst G.D., Lindemans J., Russcher H., Hofman A., et al. C-reactive protein levels, blood pressure and the risks of gestational hypertensive complications: the Generation R Study. JHypertens 2011, 29:2413-2421.
39. Malek A., Bersinger N.A., Di Santo S., Mueller M.D., Sager R., Schneider H., et al. C-reactive protein production in term human placental tissue. Placenta 2006, 27:619-625.
40. Saks G.P., Seyani L., Lavery S., Trew G. Maternal C-reactive protein levels are raised at 4 weeks of gestation. Hum Reprod 2004, 19:1025-1030.
41. Tjoa M.L., van Vugt M.G., Go A.T., Blankenstein M.A., Ondejans C.B., van Wijk I.J. Elevated C reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. JReprod Immunol 2003, 59:29-37.
42. Kumru S., Godekmerdan A., Kutlu S., Ozcan Z. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and chemical parameters in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006, 124:164-167.
43. Belo L., Santos-Silva A., Caslake M., et al. Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Preg 2003, 22:129-141.
44. Tajran D.S., Pershadsingh H.A. Can C-reactive protein function as a surrogate marker of preeclampsia?. Obstet Gynecol 2002, 99:14.
45. Kaur G., Mishra S., Sehgal A., Prasad R. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem 2008, 313:37-44.
46. Bernardi Bernardi F., Guola F., Bortolin T., Petronieho F., Dal-Pizzol F. Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. JObstet Gynecol Res 2008, 34:948-951.
47. Jouniaux E., Poston L., Burton G.J. Placental-related diseases of pregnancy: involvement of oxidative stress and implication in human evolution. Hum Reprod Update 2006, 12:747-755.
48. Hung J.H. Oxidative stress and antioxidants in preeclampsia. JClin Med Assoc 2007, 70:430-432.
49. Patil S.B., Kodliwadmath M.V., Kodliwadmath M. Lipid peroxidation and antioxidant activity in complicated pregnancies. Clin Exp Obstet Gynecol 2009, 36:110-112.
50. Kaur G., Mishra S., Sehgal A., Prasad R. Alternations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem 2008, 313:37-44.
51. Mihu D., Sabau L., Costin N., Ciorte R., Malutan A., Mihu C.M. Implications of maternal systemic oxidative stress in normal pregnancy and in pregnancy complicated by preeclampsia. JMaternal-Fetal Neonat Med 2012, 25:944-951.
52. Mohan S., Venkataramana G. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with pregnancy-induced hypertension. Indian J Physiol 2007, 51:284-288.
53. Al-Gubory K.H., Fowler P.A., Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol 2010, 42:1634-1650.
54. Regan C.L., Levine R.J., Baird D.D., Ewell M.G., Martz K.L., Sibai B.M., et al. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001, 185:572-578.
55. Myatt L. Review: reactive oxygen and nitrogen species and functional adoption of the placenta. Placenta 2010, 31(Suppl.):66-69.
56. Cindrova-Davies T. From placental oxidative stress to maternal endothelial dysfunction. Placenta Suppl A 2009, 30:55-65.
57. Can M., Sancar E., Harma M., Guven B., Mungan G., Acikgoz S. Inflammatory markers in preeclamptic patients. Clin Chem Lab Med 2011, 49:1469-1472.
58. Nunez-Gonzales J.R., Sanabria-Vera C.J., Romero-Adrian T. Serum measurements of TNF-a and TNF-a soluble receptors in normal pregnancies and preeclampsia. Invest Clin 2001, 42:171-182.
59. Karacay Ö., Sepici-Dincel A., Karcaaltincaba D., Sahin D., Yalvas S., Akyol Mesut, et al. Aquantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diab Res Clin Prac 2010, 89:231-238.
60. Aydin S., Benian A., Madazli R., Uludag S., Uzun H., Kaya S. Plasma malondialdehyde, superoxide dismutase, sE-selectin fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur J Obstet Gynec Reprod Biol 2004, 113:21-25.
61. Hwang H.S., Kwon J.Y., Kim M.A., Park Y.W., Kim Y.H. Maternal serum highly sensitive C-reactive protein in normal pregnancy and preeclampsia. Int J Gynecol Obstet 2007, 98:105-109.
62. Paternoster D.M., Fantinato S., Stella A., Nanhorngue K.N., Milani M., Plebani M. C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost 2006, 12:330-337.
63. Saker M., Mokhtari N.S., Merzouk S.A., Merzouk H., Belarbi B., Narce M. Oxidant and antioxidant status in mothers and their newborns according to birthweight. Eur J Obstet Gynecol Reprod Biol 2008, 141:95-99.
64. Karowicz-Bilinska A., Edziora-Kornatowska K., Bartosz G. Indices of oxidative stress in pregnancy with fetal growth restriction. Free Rad Res 2007, 1:870-873.